Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Genzyme
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Pharmacokinetics of Alglucosidase Alfa in Patients Aged 8 Years of Age and Older
The primary objective of this study is to characterize the pharmacokinetics of alglucosidase alfa manufactured at the 4000 L scale in patients 8 years of age and older who have a confirmed diagnosis o...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease Estudio para comparar la eficacia y la seguridad del tratamiento de sustitución enzimática de neoGAA (GZ402666) y alglucosidasa alfa administrado bisemanal en pacientes con enfermedad de Pompe de inicio tardío sin tratamiento previo
To determine the effect of neoGAA (GZ402666) treatment on respiratory muscle strength measured by percent predicted forced vital capacity (% FVC) in the upright position, as compared to alglucosidase ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Corporation
Update Il y a 4 ans
Management of the infusion-associated reactions in RRMS patients treated with Lemtrada
To assess the distribution of IARs by severity grade when Lemtrada is administered to RRMS patients who will be medicated according to specified algorithm designed to manage infusion associated reacti...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphatemic Chronic Kidney Disease Patients Not on Dialysis
To compare the efficacy and safety of sevelamer carbonate and placebo dosed three times a day (TID) on serum phosphorous levels.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Multicenter, Multinational Study of the Effects of Fabrazyme® (agalsidase beta) Treatment on Lactation and Infants
The objectives of this study are: 1. To determine whether alpha-GAL activity is present in the breast milk of mothers with Fabry disease who are being treated with Fabrazyme during lactation. 2. To me...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study of Ad2/Hypoxia Inducible Factor (HIF)-1alfa/VP16 Administered by Intramuscular Injection to Patients with No or Poor Option Chronic Critical Limb Ischemia
To evaluate the safety and tolerability of a single administration of Ad2/HIF-1alfa/VP16 by direct intramuscular (IM) injection in the treatment of patients with no or poor option chronic Critical L...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Europe BV
Update Il y a 4 ans
A Phase 4 Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Centre Study of Colesevelam as Add-on Therapy in Patients with Familial Hypercholesterolaemia
1. Assess the efficacy of colesevelam added to a maximal tolerated and stable regimen of statin and ezetimibe in further decreasing the low-density lipoprotein (LDL) cholesterol level in terms of addi...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Genzyme Europe B.V
Update Il y a 4 ans
An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of ISIS 301012 in Patients with Familial Hypercholesterolemia or Severe Hypercholesterolemia
To evaluate the safety and efficacy of extended dosing with ISIS 301012 (mipomersen) in patients with familial hypercholesterolemia or severe hypercholesterolemia on concomitant lipid-lowering therapy
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Genzyme Europe
Update Il y a 4 ans
Prospective, multicenter, double-blind, randomized, cross-over study to evaluate efficacy and safety of sevelamer in the treatment of dyslipidemia in children with persisting proteinuria
Not provided at time of registration
Country
Germany
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 2 years and 18 years
Genzyme
Update Il y a 4 ans
MOZ 15609 : Essai de phase 1-2, randomisé, combinant une évaluation de dose et une évaluation de l’efficacité et de la tolérance de plérixafor en association avec le traitement standard de mobilisation des cellules souches hématopoïétiques dans le sang périphérique et leur collecte ultérieure par aphérèse, en comparaison avec un traitement standard de mobilisation seul, chez des patients jeunes ayant une tumeur solide et candidats à une greffe autologue. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
L’objectif de cet essai est de déterminer la dose la mieux adaptée de plérixafor et d’évaluer son efficacité et sa tolérance, chez des patients jeunes ayant une tumeur solide et candidats à une greffe...
Country
France
organs
Tumeurs solides
Specialty
Chimiothérapie
,
Greffe
,
Pédiatrie
Essai clos aux inclusions
More information
Previous
1
2
3
4
5
6
Next